Methotrexate

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Methotrexate and local guidelines before prescribing.

DMARD and chemotherapy (antifolate)

Mechanism

Folate antagonist inhibiting dihydrofolate reductase.

Uses

Rheumatoid arthritis, psoriasis, Crohn disease, malignancy, ectopic pregnancy.

Dosing

4 more dose entries from the chapters
  • 2. A 24-year-old at 6 weeks has left iliac fossa pain and light bleeding. She is stable. Scan shows a 25 mm left adnexal mass, no heartbeat, empty womb. hCG is 1,200 IU/L. Answer: Unruptured tubal ectopic pregnancy suitable for methotrexate (or expectant management if hCG falling and pain-free).
    Obstetrics: Antenatal Care
  • 3. A 52-year-old woman with RA on methotrexate 15 mg weekly is prescribed trimethoprim for a UTI. She develops mouth ulcers and a sore throat. Answer: Methotrexate toxicity (myelosuppression) from an antifolate interaction.
    Rheumatology Anatomy Physiology Pharmacology
  • 2. A 58-year-old woman on methotrexate 15 mg weekly for RA is prescribed trimethoprim for a UTI. A week later she has mouth ulcers, fever and bruising. Neutrophils 0.3, platelets 35. Answer: Methotrexate toxicity (marrow suppression) from a trimethoprim interaction.
    Rheumatology: assessment, investigations and drugs
  • Stop methotrexate (1–3 months before conception per BSR); continue sulfasalazine (with folic acid 5 mg daily) and consider adding hydroxychloroquine to keep disease controlled.
    Rheumatology: assessment, investigations and drugs

Side effects

Nausea, mucositis, marrow suppression, hepatotoxicity, pneumonitis, teratogenic.

Interactions

Trimethoprim and co-trimoxazole (severe marrow suppression), NSAIDs, PPIs, penicillins reduce clearance.

Contraindications and cautions

Pregnancy, severe renal impairment, active infection

Monitoring

FBC, LFT, U&E, CXR if cough

Pregnancy and breastfeeding

Contraindicated (teratogenic)

Renal and hepatic impairment

Avoid if eGFR below 30

Overdose and reversal

Folinic acid rescue; glucarpidase in severe toxicity

Special advice

Once-weekly dosing for autoimmune disease; error causes fatalities; folic acid weekly; FBC, LFT and U&E monitoring; avoid in pregnancy.

More from the textbook: uses, cautions and other points
Where it is discussed in the book